DRREDDY Dr Reddy's Laboratories Ltd Earnings Reports Announcement 2025 - Strong Earnings Growth Dr. Reddy's Laboratories reported a strong Q3FY25 with consolidated revenues of Rs. 8,359 crores ($977 million), marking a 16% YoY growth driven by the newly acquired Nicotine Replacement Therapy business, which contributed Rs. 605 crores in revenue..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd